David Oakes

<b>[</b> ¹²³ I]β-CIT SPECT imaging assessment of the rate of Parkinson’s disease progression

Kenneth Marek, Robert B. Innis, Christopher van Dyck et al. · Neurology · 2001 · 350 citations

Medicine, Neurology, Nuclear Medicine +17

Head injury and Parkinson's disease risk in twins

Samuel M. Goldman, Caroline M. Tanner, David Oakes et al. · Annals of Neurology · 2006 · 288 citations

Life Sciences, Neurology, Neuroscience +13

Impact of sustained deprenyl (selegiline) in levodopa‐treated Parkinson's disease: A randomized placebo‐controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial

Ira Shoulson, David Oakes, Stanley Fahn et al. · Annals of Neurology · 2002 · 254 citations

Medicine, Pharmacology, Pharmacotherapy +16

Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter–Deficit Prodromal Cohort

Danna Jennings, Andrew Siderowf, Matthew Stern et al. · JAMA Neurology · 2017 · 198 citations · Full text

Medicine, Neurology, Neuroscience +17

Impaired olfaction and other prodromal features in the Parkinson At‐Risk Syndrome study

Andrew Siderowf, Danna Jennings, Shirley Eberly et al. · Movement Disorders · 2012 · 193 citations · Full text

Medicine, Neurology, Neuroscience +15